RESEARCH PAPER
Microbiological characterization and antibiotic resistance of nasopharyngeal microflora in patients with Type 2 diabetes mellitus
More details
Hide details
1
Department of Family Medicine, School of Medicine with Division of Dentistry in Zabrze, Medical University of Silesia, Katowice, Poland
Corresponding author
Elżbieta Mizgała-Izworska
Department of Family Medicine, School of Medicine, Department of Family Medicine, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Katowice, Poland, Department of Family Medicine, 41-800, Zabrze, Poland
KEYWORDS
TOPICS
ABSTRACT
Introduction and objective:
Patients with type 2 diabetes mellitus (T2DM) are predisposed to colonization of the nasopharynx by opportunistic and pathogenic bacteria due to impaired immune function. The aim of the study is to assess the prevalence and antibiotic resistance patterns of pathogenic microflora in the nasal cavity and throat of patients with T2DM.
Material and methods:
Nasal and throat swabs were collected from 88 T2DM patients. A total of 627 microbial isolates were analyzed, including 90 potentially pathogenic strains. Species identification was performed using standard culture techniques and VITEK 2. Antibiotic susceptibility was determined according to EUCAST guidelines.
Results:
Pathogenic bacteria were detected in 88% of nasal samples. The most frequently isolated Gram-positive organisms were Staphylococcus epidermidis MSCNS (33.3%) and Staphylococcus haemolyticus MSCNS (3.2%). Predominant gram–negative isolates included Proteus mirabilis, Escherichia coli, and Klebsiella pneumoniae. Gram-positive bacteria showed highest susceptibility to cephalosporins, but exhibited significant resistance to quinolones and glycopeptides (50% each). For Gram-negative isolates, resistance to penicillins with inhibitors reached 67%.
Conclusions:
The high prevalence and specific antibiotic resistance profiles of nasopharyngeal pathogens in T2DM patients underscore the importance of routine microbiological surveillance and tailored antibiotic stewardship.
REFERENCES (14)
1.
Shook JC, Thurlow LR, Conlon BP, et al. Diabetes potentiates the emergence and expansion of antibiotic resistance in Staphylococcus aureus. Sci Adv. 2025;11(7):eads1591. doi:10.1126/sciadv.ads1591. Available from:
https://www.science.org/doi/10....
2.
Rabeh M, Aminalroayaei Yamini V, Doudi M. Types of bacteria isolated from the nasopharynx of diabetics: comprehensive review 2014–2024. Int J Health Sci Public. 2025;3(1):152–163. doi:10.63053/ijhes.125. Available from:
https://ijhespub.org/index.php....
3.
Maity S, Leton N, Nayak N, et al. A systematic review of diabetic foot infections: pathogenesis, diagnosis, and management strategies. Front Clin Diabetes Healthc. 2024;5:1393309. doi:10.3389/fcdhc.2024.1393309. Available from:
https://www.frontiersin.org/ar....
4.
European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters, version 14.0. 2024. Available from:
https://www.eucast.org/clinica....
5.
Bogaert D, de Groot R, Hermans PWM. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis. 2004;4(3):144–154. doi:10.1016/S1473-3099(04)00938-7. Available from:
https://pubmed.ncbi.nlm.nih.go....
6.
Regev-Yochay G, Dagan R, Raz M, et al. Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in children. JAMA. 2004;292(6):716–720. doi:10.1001/jama.292.6.716. Available from:
https://jamanetwork.com/journa....
7.
Anafo RB, Enoch DA, Darko DM, et al. Methicillin-resistant Staphylococcus aureus (MRSA) nasal carriage among patients with diabetes at the Korle-Bu Teaching Hospital. PLoS One. 2021;16(9):e0257004. doi:10.1371/journal.pone.0257004. Available from:
https://journals.plos.org/plos....
8.
Becker K, Heilmann C, Peters G. Coagulase-negative staphylococci. Clin Microbiol Rev. 2014;27(4):870–926. doi:10.1128/CMR.00109-13. Available from:
https://journals.asm.org/doi/1....
9.
Otto M. Coagulase-negative staphylococci as reservoirs of genes facilitating MRSA infection. Bioessays. 2013;35(1):4–11. doi:10.1002/bies.201200112. Available from:
https://onlinelibrary.wiley.co....
10.
European Centre for Disease Prevention and Control; World Health Organization Regional Office for Europe. Surveillance of antimicrobial resistance in Europe, 2023 data — executive summary. Stockholm: ECDC/WHO; 2024. Available from:
https://www.ecdc.europa.eu/en/....
11.
Wang Q, Nurxat N, Zhang L, et al. Diabetes mellitus promotes the nasal colonization of highly virulent Staphylococcus aureus via the SaeRS two-component system. Emerg Microbes Infect. 2023;12(2):2276335. doi:10.1080/22221751.2023.2276335. Available from:
https://pubmed.ncbi.nlm.nih.go....
12.
Dei-Dzeha MS, Dayie NTKD, Atiase Y, et al. Comparison of nasopharyngeal bacteriological profile between patients with diabetes and healthy individuals in Accra, Ghana. BMC Res Notes. 2024;17:362. doi:10.1186/s13104-024-07003-3. Available from:
https://bmcresnotes.biomedcent....
13.
World Health Organization (WHO). Global antimicrobial resistance and use surveillance system (GLASS) report 2022. Geneva: WHO; 2022. Available from:
https://iris.who.int/bitstream....
14.
Mizgała-Izworska E, Żywiec J, Klekotka R, et al. Bacteriological profile of the nasopharynx in patients with type 2 diabetes. Ann Agric Environ Med. 2023;30(1):183–189. doi:10.26444/aaem/158024. Available from:
https://aaem.pl/Bacteriologica....